摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-amino-3-hydroxymethyl-1,2,3,4-tetrahydroisoquinoline | 153705-57-8

中文名称
——
中文别名
——
英文名称
2-amino-3-hydroxymethyl-1,2,3,4-tetrahydroisoquinoline
英文别名
(2-amino-3,4-dihydro-1H-isoquinolin-3-yl)methanol
2-amino-3-hydroxymethyl-1,2,3,4-tetrahydroisoquinoline化学式
CAS
153705-57-8
化学式
C10H14N2O
mdl
——
分子量
178.234
InChiKey
ATSWTIVERWZSOV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    49.5
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis and conformational analysis of tetrahydroisoquinoline- and piperidine-fused 1,3,4,2-oxadiazaphosphinanes, new ring systems
    作者:Zita Zalán、Tamás A. Martinek、László Lázár、Reijo Sillanpää、Ferenc Fülöp
    DOI:10.1016/j.tet.2006.01.018
    日期:2006.3
    representatives of these ring systems, were prepared. NMR and X-ray diffraction studies revealed that, independently of the P-substituent and the relative configuration of the phosphorus atom, 13, 14, 17 and 18 could be characterized by trans-connected hetero rings and the chair conformation of the 1,3,4,2-oxadiazaphosphinane moiety, while the stereochemistry of the connection of the hetero rings in the 1,3,4
    通过四氢异喹啉哌啶-1,2-二基醇与苯基膦酰二和苯基二,环化P的1,6,7,11b四氢-4- -epimeric非对映体ħ -oxadiazaphosphino -1,3,4,2 [5,4 -一个]异喹啉-3-氧化物(13和14),1,6,11,11a四氢-4- ħ -1,3,4,2-oxadiazaphosphino并[4,5- b ]异喹啉-3-氧化物(15和16)和1,6,7,8,9,9a-hexahydro-4 H-吡啶[1,2- d ] [1,3,4,2]草二氮膦3氧化物(17和18),这些环系统的第一批代表已经准备好了。NMR和X射线衍射研究显示,独立于P -取代和原子的相对构型,13,14,17和18可以通过反式连接的杂环和1,3的椅式构象的特征在于1,4,2-氧杂二氮杂膦烷部分,而线性地稠合于四氢异喹啉(15和16)的1,3,4,2-氧杂二氮杂膦杂环中的杂环连接的
  • INHIBITORS OF COPPER-CONTAINING AMINE OXIDASES
    申请人:Biotie Therapies Corp.
    公开号:EP1301495A2
    公开(公告)日:2003-04-16
  • [EN] INHIBITORS OF COPPER-CONTAINING AMINE OXIDASES<br/>[FR] INHIBITEUR D'AMINE OXYDASES CONTENANT DU CUIVRE
    申请人:BIOTIE THERAPIES CORP
    公开号:WO2002002541A2
    公开(公告)日:2002-01-10
    The present invention is directed to 1,3,4-oxadiazine compounds that function as inhibitors of copper-containg amine oxidases commonly known as semicarbazide-sensitive amine oxidases (SSAO), including the human SSAO known as Vascular Adhesion Protein-1 (VAP-1). These SSAO inhibitors have therapeutic utility as drugs to treat conditions and diseases including, but not limited to, a number of inflammatory conditions and diseases (in particular chronic inflammatory conditions such as chronic arthritis, inflammatory bowel diseases, and chronic skin dermatoses), diseases related to carbohydrate metabolism and to abberations in adipocyte differentiation or function and smooth muscle cell function, and vascular diseases. The compounds have the general formula (I): or a tautomer, isomer, hydrazino alcohol degradation product, or a pharmaceutically acceptable solvate, hydrate, or salt thereof, wherein R?1, R2, R3, R4, R5,R6, R7, and R8¿ are as defined her ein.
查看更多